Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120 - PubMed (original) (raw)
Comparative Study
Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120
E O Freed et al. J Virol. 1994 Apr.
Abstract
The domains of the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein that are required for envelope function have been partially characterized. Little is known, however, about the nature of the interactions between these domains. To identify regions of the HIV-1 envelope glycoprotein that are involved in interactions necessary for proper envelope function, we constructed a series of 14 envelope recombinants between the env genes of two HIV-1 isolates. The envelope chimeras were examined for their ability to induce syncytia, to be proteolytically processed, and to function during a spreading viral infection. Our results demonstrate that the exchange between the two isolates of the first and second hypervariable regions (V1/V2) of gp120 results in defects in envelope glycoprotein processing, syncytium formation, and infectivity. Long-term passage of cultures infected with virus bearing a V1/V2 chimeric envelope glycoprotein leads to the emergence of a revertant virus with replication characteristics comparable to those of the wild type. Analysis of the revertant indicated that an Ile-->Met change in the C4 region of gp120 (between hypervariable regions V4 and V5) is responsible for the revertant phenotype. This single amino acid change restores infectivity without significantly affecting gp160 processing, CD4 binding, or the levels of virion-associated gp120. While the Ile-->Met change in C4 greatly enhances the fusogenic potential of the V1/V2 chimeric envelope glycoprotein, it has a detrimental effect on syncytium formation when analyzed in the context of the wild-type envelope. These results suggest that an interaction required for proper envelope glycoprotein function occurs between the V1/V2 and C4 regions of gp120.
Similar articles
- Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.
Koito A, Harrowe G, Levy JA, Cheng-Mayer C. Koito A, et al. J Virol. 1994 Apr;68(4):2253-9. doi: 10.1128/JVI.68.4.2253-2259.1994. J Virol. 1994. PMID: 8139010 Free PMC article. - Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions.
Wyatt R, Sullivan N, Thali M, Repke H, Ho D, Robinson J, Posner M, Sodroski J. Wyatt R, et al. J Virol. 1993 Aug;67(8):4557-65. doi: 10.1128/JVI.67.8.4557-4565.1993. J Virol. 1993. PMID: 8331723 Free PMC article. - Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
Wyatt R, Moore J, Accola M, Desjardin E, Robinson J, Sodroski J. Wyatt R, et al. J Virol. 1995 Sep;69(9):5723-33. doi: 10.1128/JVI.69.9.5723-5733.1995. J Virol. 1995. PMID: 7543586 Free PMC article. - CD4 activation of HIV fusion.
Sattentau QJ. Sattentau QJ. Int J Cell Cloning. 1992 Nov;10(6):323-32. doi: 10.1002/stem.5530100603. Int J Cell Cloning. 1992. PMID: 1281202 Review. - The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection.
Freed EO, Martin MA. Freed EO, et al. J Biol Chem. 1995 Oct 13;270(41):23883-6. doi: 10.1074/jbc.270.41.23883. J Biol Chem. 1995. PMID: 7592573 Review. No abstract available.
Cited by
- In Vivo Analysis of Infectivity, Fusogenicity, and Incorporation of a Mutagenic Viral Glycoprotein Library Reveals Determinants for Virus Incorporation.
Salamango DJ, Alam KK, Burke DH, Johnson MC. Salamango DJ, et al. J Virol. 2016 Jun 24;90(14):6502-14. doi: 10.1128/JVI.00804-16. Print 2016 Jul 15. J Virol. 2016. PMID: 27147747 Free PMC article. - Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag.
Ono A, Waheed AA, Freed EO. Ono A, et al. Virology. 2007 Mar 30;360(1):27-35. doi: 10.1016/j.virol.2006.10.011. Epub 2006 Nov 13. Virology. 2007. PMID: 17095032 Free PMC article. - HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice.
Keller PW, Adamson CS, Heymann JB, Freed EO, Steven AC. Keller PW, et al. J Virol. 2011 Feb;85(4):1420-8. doi: 10.1128/JVI.01926-10. Epub 2010 Nov 24. J Virol. 2011. PMID: 21106735 Free PMC article. - Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting.
Saad JS, Ablan SD, Ghanam RH, Kim A, Andrews K, Nagashima K, Soheilian F, Freed EO, Summers MF. Saad JS, et al. J Mol Biol. 2008 Oct 3;382(2):434-47. doi: 10.1016/j.jmb.2008.07.027. Epub 2008 Jul 16. J Mol Biol. 2008. PMID: 18657545 Free PMC article. - Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera.
Wrin T, Loh TP, Vennari JC, Schuitemaker H, Nunberg JH. Wrin T, et al. J Virol. 1995 Jan;69(1):39-48. doi: 10.1128/JVI.69.1.39-48.1995. J Virol. 1995. PMID: 7983734 Free PMC article.
References
- J Biol Chem. 1990 Jun 25;265(18):10373-82 - PubMed
- J Virol. 1994 Feb;68(2):1029-39 - PubMed
- J Virol. 1990 Dec;64(12):5701-7 - PubMed
- J Virol. 1990 Dec;64(12):6314-8 - PubMed
- J Virol. 1991 Jan;65(1):190-4 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous